miDiagnostics is developing a next-generation diagnostic platform based on a silicon nanofluidic processor.
miDiagnostics has raised $31.5M in total funding. The most recent round was Series D. The last funding was announced in December 2024.
miDiagnostics's investors include European Investment Bank, Thermo Fisher Scientific, Alychlo, Pamica AB, Urbain Vandeurzen.
miDiagnostics is headquartered in Leuven, Belgium.
miDiagnostics is developing a next-generation diagnostic platform based on a silicon nanofluidic processor.
miDiagnostics is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"miDiagnostics — Funding & Investors." VCBacked, December 4, 2024, https://www.vcbacked.co/company/midiagnostics. Accessed October 29, 2026.
VCBacked. (2024). miDiagnostics — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/midiagnostics
{{cite web |title=miDiagnostics — Funding & Investors |url=https://www.vcbacked.co/company/midiagnostics |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated